[1]Morogina;Nasibulin;Klyuev[PetroleumChemistry,1998,vol.38,#4,p.251-255]
[2]Adamsetal.[JournaloftheAmericanChemicalSociety,1926,vol.48,p.1768]
[3]Adamsetal.[JournaloftheAmericanChemicalSociety,1926,vol.48,p.1768]Brill[JournaloftheAmericanChemicalSociety,1921,vol.43,p.1323]
[4]Matsunaga;Miyajima[MolecularCrystalsandLiquidCrystals(1969-1991),1984,vol.104,#3-4,p.353-359]
[5]Voronin;Nasibulin;Klyuev[RussianJournalofOrganicChemistry,1997,vol.33,#11,p.1613-1615]
[6]Morogina;Nasibulin;Klyuev[PetroleumChemistry,1998,vol.38,#4,p.251-255]
[7]Kaur,Gurmeet;Narayanan,VenL.;Risbood,PrabhakarA.;Hollingshead,MelindaG.;Stinson,ShermanF.;Varma,RaviK.;Sausville,EdwardA.[BioorganicandMedicinalChemistry,2005,vol.13,#5,p.1749-1761]
[8]CurrentPatentAssignee:Bayer-FR2264804,1975,B1[Chem.Abstr.,1976,vol.84,#58989][Chem.Abstr.,1976,vol.84,#58989]
[9]CurrentPatentAssignee:Bayer&Co.-DE211801,1800,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972]
[10]CurrentPatentAssignee:Bayer&Co.-DE211801,1800,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972]
[1]Budeanuetal.[1955,vol.1,p.345,349][Chem.Abstr.,1957,p.10751]
[1]CurrentPatentAssignee:PFIZERINC-WO2010/116270,2010,A1Locationinpatent:Page/Pagecolumn28-29
[2]Kazemi,Foad;Kiasat,AliReza;Mombaini,Began[Phosphorus,SulfurandSiliconandtheRelatedElements,2004,vol.179,#6,p.1187-1191]
[3]CurrentPatentAssignee:Bayer&Co.-DE211801,1800,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.9,p.972]
[1]CurrentPatentAssignee:Bayer-FR2264804,1975,B1[Chem.Abstr.,1976,vol.84,#58989][Chem.Abstr.,1976,vol.84,#58989]
[1]Roclofsen,D.P.etal.[RecueildesTravauxChimiquesdesPays-Bas,1970,vol.89,p.193-210]
[2]Mai,VanHung;Nikonov,GeorgiiI.[Organometallics,2016,vol.35,#7,p.943-949]
Title: Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
Journal: Bioorganic & medicinal chemistry letters 20111215
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501